Found 683 matching trials
XP-005 Personalized Vaccine Alone or in Combination With Toripalimab for the Prevention of Relapse After Remission in Acute Myeloid Leukemia EARLY_PHASE1 The main objective of this study is to observe and evaluate the safety and ...
Show More Location
Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Learn More & Join Trial
A Study of RC48-ADC Combined with JS001 for Postoperative Adjuvant Treatment of Upper Tract Urothelial Carcinoma PHASE2 This study will evaluate the efficacy and safety of intravenous RC48-ADC co...
Show More Location
Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China
Learn More & Join Trial
A Single-arm, Open-label, Prospective Clinical Study of Surufatinib Combined With Immunotherapy and Chemotherapy for Unresectable or Metastatic Biliary Tract Cancer. PHASE2 This is a single-arm, open-label, prospective clinical study aimed at obser...
Show More Location
Multiple Locations
Learn More & Join Trial
Neoadjuvant vs Adjuvant in Locally Advanced Recurrent NPC PHASE3 A multicenter randomized controlled study of surgery combined with neoadjuv...
Show More Location
Eye& ENT Hospital, Fudan University
Learn More & Join Trial
Surgery vs. Radical Chemoradiotherapy for Esophageal SCC After Neoadjuvant Immunochemotherapy PHASE3 This is a Phase III, multicenter, open-label, randomized controlled trial. ...
Show More Location
Henan Cancer Hospital
Learn More & Join Trial
A Study of JS009 Monotherapy and JS009 as a Triple Combination Therapy in Patients With Advanced Malignancies PHASE1 The study is being conducted to evaluate the Safety, Tolerability, Pharmaco...
Show More Location
Multiple Locations
Learn More & Join Trial
A Single-center Phase II Study to Investigate the Immune Maintenance Therapy Pattern in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Who Have Achieved MPR After Neoadjuvant Immunotherapy Combined With Chemotherapy PHASE2 Head and neck cancer is the malignant tumor with the highest morbidity and ...
Show More Location
Tianjin Medical University Cancer Institute and Hospital
Learn More & Join Trial
PD-1 Antibody Combined With Chemoradiotherapy in Recurrent Nasopharyngeal Carcinoma Patients PHASE3 This is a multicenter, randomized controlled, phase III clinical trial. The...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Neoadjuvant Chemotherapy Plus Toripalimab in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma PHASE2 Neoadjuvant chemotherapy plus toripalimab in patients with locoregionally a...
Show More Status
Active Not Recruiting
Location
Zhejiang Cancer Hospital
Learn More & Join Trial
Anti-PD-1 Antibody Plus Regorafenib in Refractory Microsatellite Stable Metastatic Colorectal Cancer N/A Managements for refractory proficient mismatch repair (pMMR) or microsatell...
Show More Location
Hunan Cancer hospital
Learn More & Join Trial